JENNIFER METSCHER: Open Payments
NPI 1477953479 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 21 payments from 13 companies in 2025. Trend: 2023 $405 · 2024 $482 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $75 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $43 |
| Lundbeck LLC | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| SANOFI PASTEUR INC. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Insulet Corporation | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: REXULTI, Auvelity, Kerendia, TRELEGY ELLIPTA, SHINGRIX, BEYFORTUS, TAVNEOS, QULIPTA.
Industry payments across MO — which companies pay providers there.
